Kearns GL - Search Results

1

Cytochrome P450 3A: ontogeny and drug disposition.

de Wildt SN, Kearns GL, Leeder JS, van den Anker JN. de Wildt SN, et al. Among authors: kearns gl. Clin Pharmacokinet. 1999 Dec;37(6):485-505. doi: 10.2165/00003088-199937060-00004. Clin Pharmacokinet. 1999. PMID: 10628899 Review.

2

Pharmacokinetics and pharmacodynamics of famotidine in paediatric patients.

James LP, Kearns GL. James LP, et al. Among authors: kearns gl. Clin Pharmacokinet. 1996 Aug;31(2):103-10. doi: 10.2165/00003088-199631020-00002. Clin Pharmacokinet. 1996. PMID: 8853932 Review.

3

Clinical pharmacokinetics in infants and children. A reappraisal.

Kearns GL, Reed MD. Kearns GL, et al. Clin Pharmacokinet. 1989;17 Suppl 1:29-67. doi: 10.2165/00003088-198900171-00005. Clin Pharmacokinet. 1989. PMID: 2692939 Review.

4

Evaluation of occult acetaminophen hepatotoxicity in hospitalized children receiving acetaminophen. Pediatric Pharmacology Research Unit Network.

James LP, Wilson JT, Simar R, Farrar HC, Kearns GL, Simpson PM, Hinson JA, Pumford NR; Pediatric Pharmacology Research Unit Network. James LP, et al. Among authors: kearns gl. Clin Pediatr (Phila). 2001 May;40(5):243-8. doi: 10.1177/000992280104000501. Clin Pediatr (Phila). 2001. PMID: 11388672

5

Hepatic drug clearance in patients with mild cystic fibrosis.

Kearns GL, Crom WR, Karlson KH Jr, Mallory GB Jr, Evans WE. Kearns GL, et al. Clin Pharmacol Ther. 1996 May;59(5):529-40. doi: 10.1016/S0009-9236(96)90181-2. Clin Pharmacol Ther. 1996. PMID: 8646824

6

Pharmacokinetics and metabolism of oral midazolam in preterm infants.

de Wildt SN, Kearns GL, Hop WC, Murry DJ, Abdel-Rahman SM, van den Anker JN. de Wildt SN, et al. Among authors: kearns gl. Br J Clin Pharmacol. 2002 Apr;53(4):390-2. doi: 10.1046/j.1365-2125.2002.01223.x. Br J Clin Pharmacol. 2002. PMID: 11966671 Free PMC article.

7

Glucuronidation in humans. Pharmacogenetic and developmental aspects.

de Wildt SN, Kearns GL, Leeder JS, van den Anker JN. de Wildt SN, et al. Among authors: kearns gl. Clin Pharmacokinet. 1999 Jun;36(6):439-52. doi: 10.2165/00003088-199936060-00005. Clin Pharmacokinet. 1999. PMID: 10427468 Review.

8

Paediatric labelling requirements. Implications for pharmacokinetic studies.

Wilson JT, Kearns GL, Murphy D, Yaffe SJ. Wilson JT, et al. Among authors: kearns gl. Clin Pharmacokinet. 1994 Apr;26(4):308-25. doi: 10.2165/00003088-199426040-00006. Clin Pharmacokinet. 1994. PMID: 8013163 Review.

9

Ceftibuten pharmacokinetics and pharmacodynamics. Focus on paediatric use.

Kearns GL, Young RA. Kearns GL, et al. Clin Pharmacokinet. 1994 Mar;26(3):169-89. doi: 10.2165/00003088-199426030-00002. Clin Pharmacokinet. 1994. PMID: 8194281 Review.

10

Pharmacokinetic studies in paediatric patients. Clinical and ethical considerations.

Kauffman RE, Kearns GL. Kauffman RE, et al. Among authors: kearns gl. Clin Pharmacokinet. 1992 Jul;23(1):10-29. doi: 10.2165/00003088-199223010-00002. Clin Pharmacokinet. 1992. PMID: 1617856 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results